Objective-Interleukin 17A (IL17A) is involved in many inflammatory processes, but its role in atherosclerosis remains controversial. We examined the role of IL17A in mouse and human atherosclerosis. Methods and Results-Atherosclerosis was induced in apolipoprotein E (ApoE) Ϫ/Ϫ and IL17A/ApoE Ϫ/Ϫ mice using high-fat feeding, angiotensin II infusion, or partial carotid ligation. In ApoE Ϫ/Ϫ mice, 3 months of high-fat diet induced interferon-␥ production by splenic lymphocytes, and this was abrogated in IL17A/ApoE Ϫ/Ϫ mice. IL17A/ApoE Ϫ/Ϫ mice had reduced aortic superoxide production, increased aortic nitric oxide levels, decreased aortic leukocyte and dendritic cell infiltration, and reduced weight gain after a high-fat diet compared with ApoE Ϫ/Ϫ mice. Despite these favorable effects, IL17A deficiency did not affect aortic plaque burden after a high-fat diet or angiotensin II infusion. In a partial carotid ligation model, IL17A deficiency did not affect percentage of stenosis but reduced outward remodeling. In this model, neutralization of the related isoform, IL17F, in IL17A/ApoE Ϫ/Ϫ mice did not alter atherosclerosis. Finally, there was no correlation between IL17A levels and carotid intima-media thickness in humans.
IL17 has been detected in human atherosclerotic lesions. 6 Eid et al 7 found that human coronary artery infiltrating T cells produce IL17, interferon-␥ (IFN-␥), or both and that IL17 and IFN-␥ act synergistically to induce proinflammatory responses in vascular smooth muscle cells. Patients with acute myocardial infarction and unstable angina have increased peripheral Th17 cells and IL17 levels. 8 We previously showed that IL17A is required for the maintenance of angiotensin II-induced hypertension and vascular dysfunction, both of which are risk factors for atherosclerosis. 9 One might therefore predict that IL17A is proatherogenic. In prior studies, IL17 seemed to reduce, increase, or have no effect on atherosclerosis depending on the experimental model and method of inhibition. 10 -16 Unfortunately, most of the approaches used in these prior reports could be complicated by nonspecific/off-target effects of the interventions or incomplete IL17 suppression.
We therefore sought to accurately examine the role of IL17 in atherosclerosis by generating IL17A/apolipoprotein E (ApoE) Ϫ/Ϫ double-deficient mice and to inducing lesions using 3 separate models (high-fat diet, angiotensin II infusion, and partial carotid ligation). We also compared carotid intima-media thickness, a surrogate marker of early atherosclerosis, with serum levels of IL17A in a population of relatively healthy humans aged 50 to 69 years. Our results indicate that although IL17A modulates some aspects of systemic and vascular inflammation and vascular function, inhibition of IL17A is insufficient to decrease atherosclerotic plaque burden.
Materials and Methods

Animals and Induction of Atherosclerosis
The Institutional Animal Care and Use Committee at Emory University approved all animal protocols. IL17A Ϫ/Ϫ mice were generated as described in Nakae et al 17 and back-crossed to the C57BL/6J back-ground. ApoE Ϫ/Ϫ mice on a C57BL/6J background were obtained from the Jackson Laboratory and crossed to IL17A Ϫ/Ϫ mice to generate homozygous IL17/ApoE Ϫ/Ϫ mice. At 8 to 11 weeks of age, male mice were started on a diet composed of 35 kcal% fat, 1.25% cholesterol, and 0.5% cholate (catalog no. D12336, OpenSource Diets) for 12 weeks. Other mice underwent implantation of osmotic minipumps (model 2004, Alzet Corp) for infusion of angiotensin II (A2900, Sigma-Aldrich) at a dose of 1000 ng/kg per minute for 4 weeks. In separate mice, partial left carotid ligation was performed as previously described. 18 These animals were fed a high-fat diet for the next 2 weeks. To examine a potential role of IL17F, IL17A/ApoE Ϫ/Ϫ were treated with anti-IL17F neutralization polyclonal antibody (100 g/mouse per injection, catalog no. AF2057, R&D Systems) or its isotype control (goat IgG, 100 g/mouse per injection, catalog no. AB-108-C, R&D Systems) once a week for 3 weeks starting 1 week before carotid ligation.
Human Carotid Intima-Media Thickness Evaluation and IL17A Determinations
Carotid intima-media thickness measured by B mode ultrasound was compared with IL17A levels (measured using reagents from R&D Systems and a Luminex platform) in 16 healthy subjects aged 50 to 69 years.
Statistics
Data are expressed as meanϮstandard error of the mean. A probability value Յ0.05 was considered significant.
See supplemental material, available online at http://atvb. ahajournals.org, for an expanded Materials and Methods section.
Results
IL17A Is Upregulated in Response to Diet-Induced Atherosclerosis and Promotes IFN-␥ Production
To determine the role of IL17A in atherosclerosis, we first examined the effect of high-fat feeding on T cell production of IL17A. Splenic lymphocytes were isolated from ApoE Ϫ/Ϫ mice fed a high-fat diet or normal chow (regular) diet for 3 months and cultured on anti-CD3 plates for 48 hours. As Figure 1 . Cytokine production, body weight, and vascular reactive oxygen species in ApoE Ϫ/Ϫ and IL17/ApoE Ϫ/Ϫ mice in response to highfat diet. Splenic lymphocytes from ApoE Ϫ/Ϫ and IL17/ApoE Ϫ/Ϫ mice fed a regular (Reg) diet or high-fat (HF) diet for 3 months were cultured on anti-CD3 plates, and the culture supernatants were analyzed for IL17A using ELISA (A) or a cytokine bead array (B to D) (nϭ4 to 7 per group). Body weight (in grams) was measured at baseline and after 3 months of HF diet in ApoE Ϫ/Ϫ and IL17/ApoE Ϫ/Ϫ mice (E) (nϭ12 to 15 per group). Aortic superoxide production was measured by dihydroethidium-high-performance liquid chromatography (F) (nϭ5 to 7 per group). Aortic nitric oxide levels after 3 months of high-fat diet feeding were measured by electron spin resonance (ESR). Example ESR spectra (G) and summary data (H) are shown (nϭ4 to 5 per group). Data in A and H were analyzed using the Student's t test. Data in E were analyzed using 2-way repeated-measures ANOVA. Other statistical data were analyzed using 1-way ANOVA with the Neuman-Keuls post hoc test.
shown in Figure 1A , a high-fat diet markedly increased release of IL17A by these cells.
We then examined how IL17A affects production of the Th1 cytokines IFN-␥ and tumor necrosis factor-␣ and the Th2 cytokines IL4 and IL5. IL17A-deficient mice were crossed with ApoE-deficient mice to generate homozygous IL17/ ApoE Ϫ/Ϫ mice. IFN-␥ and IL5 production by splenic lymphocytes, as detected by cytokine bead array, were markedly increased by a high-fat diet in ApoE Ϫ/Ϫ mice ( Figure 1B and 1D). The increase in IFN-␥, but not IL5, was significantly abrogated in IL17/ApoE Ϫ/Ϫ mice, indicating that IL17A is necessary for IFN-␥ but not IL5 production in response to a high-fat diet ( Figure 1B and 1D). Tumor necrosis factor-␣ production was not altered by a high-fat diet and was similar between ApoE Ϫ/Ϫ mice and IL17/ApoE Ϫ/Ϫ mice ( Figure  1C ). IL4 production was undetectable in mice fed a regular diet and was increased in response to a high-fat diet to a similar degree in ApoE Ϫ/Ϫ and IL17/ApoE Ϫ/Ϫ mice (data not shown). Thus, production of both Th1 (IFN-␥) and Th2 (IL4 and IL5) cytokines increased in response to a high-fat diet, but only the increase in IFN-␥ was IL17A dependent.
Effect of IL17A on Weight Gain and Plasma Lipids in Response to High-Fat Diet
Body weight and plasma lipids were not significantly different between ApoE Ϫ/Ϫ and IL17/ApoE Ϫ/Ϫ mice at baseline ( Figure 1E and Table) . High-fat feeding increased weight by 2.6 g in ApoE Ϫ/Ϫ mice but not in IL17/ApoE Ϫ/Ϫ , suggesting that IL17A may play a role in weight gain in response to a high-fat diet ( Figure 1E ).
IL17A Promotes Superoxide Production and Decreases Nitric Oxide Levels in Response to High-Fat Diet
Atherosclerosis increases vascular production of reactive oxygen species and decreases nitric oxide production. We determined the effect of IL17A on aortic superoxide production using ApoE Ϫ/Ϫ and IL17/ApoE Ϫ/Ϫ mice fed a regular diet or high-fat diet for 3 months. Baseline levels of superoxide were similar between ApoE Ϫ/Ϫ and IL17/ApoE Ϫ/Ϫ mice. The high-fat diet, however, increased aortic superoxide production in ApoE Ϫ/Ϫ mice by approximately 2-fold, and this increase was significantly blunted in IL17/ApoE Ϫ/Ϫ mice ( Figure 1F ). Thus, IL17 is necessary for high-fat diet induced elevations in vascular superoxide.
Aortic nitric oxide levels correlate with endotheliumdependent relaxation and improved vascular function. Aortic nitric oxide levels in ApoE Ϫ/Ϫ and IL17/ApoE Ϫ/Ϫ mice fed a high-fat diet were measured using electron spin resonance. Nitric oxide production by aortic rings of IL17/ApoE Ϫ/Ϫ mice were increased compared with aortic rings of ApoE Ϫ/Ϫ mice ( Figure 1G and 1H).
IL17A Deficiency Has No Effect on Atherosclerotic Plaque Area or Aneurysm Formation but Decreases Aortic Inflammatory Cell Infiltration
To determine the effect of IL17A on atherosclerotic plaque development, we quantified plaque area in the descending aorta (Figure 2A and 2B) and aortic root ( Figure 2C and 2D) in ApoE Ϫ/Ϫ and IL17/ApoE Ϫ/Ϫ mice fed a high-fat diet for 3 months. Surprisingly, plaque area in these regions was similar between IL17/ApoE Ϫ/Ϫ mice and age-matched ApoE Ϫ/Ϫ controls. We then investigated whether plaque morphology was different using Russell-Movat pentachrome staining ( Figure 3A ). No major differences were noted among extracellular matrix components such as elastin (black), collagen (yellow), and mucins (blue-green). Flow cytometry of whole aortas, however, revealed a modest decrease in total leukocytes (CD45ϩ cells) and dendritic (CD11b-11cϩ) cells and a trend toward reduction of aortic macrophages (CD11bϩF4/ 80ϩ cells) and T cells (CD3ϩ cells) in the IL17A-deficient mice ( Figure 3B ). Immunostaining of atherosclerotic plaques demonstrated a decrease in total macrophage content within lesions ( Figure 3C ). Thus, although plaque size and extracellular matrix content were similar between ApoE Ϫ/Ϫ and IL17/ApoE Ϫ/Ϫ mice, the plaques did appear to be less inflammatory in IL17/ApoE Ϫ/Ϫ mice. Angiotensin II enhances atherosclerosis in ApoE Ϫ/Ϫ mice. 19 Because we previously showed that angiotensin II stimulates T cell production of IL17A, 9 we examined the role of IL17A in angiotensin II induced atherosclerosis. Angiotensin II (1000 ng/kg per minute) was infused via osmotic minipump for 4 weeks in ApoE Ϫ/Ϫ and age-matched IL17/ ApoE Ϫ/Ϫ mice. Angiotensin II induced atherosclerosis in ApoE Ϫ/Ϫ and IL17/ApoE Ϫ/Ϫ mice to a similar extent, indicating that IL17A does not contribute to plaque development in an angiotensin II-induced model of atherosclerosis ( Figure  4A ). Plasma lipids following 4 weeks of angiotensin II were similar between ApoE Ϫ/Ϫ and IL17/ApoE Ϫ/Ϫ mice (data not shown).
Infusion of angiotensin II at this dose, 1000 ng/kg per minute, induces aneurysm formation in ApoE Ϫ/Ϫ mice. 19 We found that aneurysm formation was similar in ApoE Ϫ/Ϫ mice and IL17/ ApoE Ϫ/Ϫ mice (18% and 20%, respectively), suggesting that IL17A does not influence aneurysm development.
IL17F Is Upregulated in IL17A-Deficient Mice and Is Increased by High-Fat Diet
IL17F is closely related to IL17A, can dimerize with IL17A, and binds to the same receptor. Von Vietinghoff and Ley 20 showed that IL17F was upregulated in IL17A-deficient mice. Therefore, we examined whether IL17F was also upregulated in our IL17/ApoE Ϫ/Ϫ mice and whether IL17F production was influenced by a high-fat diet. Interestingly, IL17F production at baseline (regular diet) was markedly increased in IL17/ApoE Ϫ/Ϫ mice. A high-fat diet further increased IL17F production, and IL17F levels were similar in ApoE Ϫ/Ϫ and IL17/ApoE Ϫ/Ϫ mice after 3 months of high-fat diet ( 4B). This elevation in IL17F in our model raised the possibility that IL17F could be assuming a compensatory or redundant role in plaque formation in the absence of IL17A.
Neutralization of IL17F in IL17A-Deficient Mice Has No Effect on Partial Carotid Ligation-Induced Atherosclerosis
We further examined the effect of IL17A with and without concomitant IL17F neutralization in a rapid (2-week) partial carotid ligation model of atherosclerosis described by Nam et al. 18 Interestingly, we found that percentage of stenosis of the ligated carotid artery was not affected by the absence of IL17A, but vessel diameter (as measured by internal elastic lamina area) was significantly decreased in the IL17Adeficient mice, indicating that IL17A may play an important role in outward remodeling of vessels under conditions of disturbed flow ( Figure 5A and 5B). To determine whether IL17F compensates for the loss of IL17A during the development of atherosclerosis, we administered an IL17F neutralizing antibody weekly beginning 1 week before carotid ligation. IL17F neutralization had no effect on internal elastic lamina area or percentage of stenosis ( Figure 5A and 5C ), arguing against a significant role of IL17F in atherosclerosis development.
IL17A Levels Do Not Correlate With Carotid Intima-Media Thickness in Humans
Increased carotid intima-media thickness is an early subclinical marker of atherosclerosis and a predictor of future cardiovascular events. 21 We examined serum IL17A levels and carotid intima-media thickness in a small population of healthy humans aged 50 to 69 years. As shown in the Supplemental Figure, there was no correlation between IL17A levels and either mean or far wall carotid intimamedia thickness, suggesting that IL17A does not participate in human atherosclerotic plaque formation.
Discussion
In the present study, we found that IL17A modulates systemic and vascular inflammation by stimulating IFN-␥ production and increasing vascular reactive oxygen species and vascular leukocyte infiltration, and it contributes to weight gain in response to high-fat diet. Despite these favorable effects, IL17A had no effect on gross lesion size in either mouse or human atherosclerosis. Furthermore, neutralization of a related cytokine, IL17F, had no effect on atherosclerosis in a rapid partial carotid ligation model. To our knowledge, this is the first study to use a genetic deletion of IL17A and ApoE to study the role of IL17A in atherosclerosis. Several recent studies on this topic have provided conflicting results showing that IL17A reduces, increases, or has no effect on atherosclerotic plaque development. 10 -16 Differences in these results may be due to the methods used for eliminating IL17A, nonspecific effects of the interventions, or lack of complete elimination in some studies.
Despite finding no effect on plaque burden, we did find decreased vascular inflammation in the IL17A-deficient mice. We used 2 independent methods to assess vascular infiltration of inflammatory cells. We first used flow cytometry of whole aortas and found that total leukocytes and dendritic cells were significantly reduced in IL17A-deficient mice, with a trend toward reduced macrophages and T cells. Flow cytometry has the limitation that the entire aorta is analyzed, which could underestimate differences that could be present if only lesions were analyzed. We then performed immunostaining on atherosclerotic plaques and found that plaque macrophage content appeared to be reduced in IL17Adeficient mice. These results are consistent with reports by Erbel et al 12 and Smith et al, 13 who also found that IL17A blockade reduced plaque macrophage content. A potential mechanism for this finding is that IL17A can act on vascular wall cells to induce the production of numerous cytokines and chemokines, such as IL6, CXCL8, CCL5, CXCL1, GCSF3, and monocyte chemoattractant protein-2. 9,13 Monocyte chemoattractant protein-2 binds to cell surface receptors such as CCR1 and CCR5, expressed on leukocytes, 22 and CXCL1 is important in monocyte recruitment into the artery wall. In addition, monocytes express the IL17RA receptor, and IL17A directly influences monocyte chemotaxis. 23, 24 We and others have shown that IL17A promotes inflammation in a manner similar to that observed in the present study. Shahrara et al 25 demonstrated that in rheumatoid arthritis, IL17A promotes monocyte migration into synovial tissue via upregulation of chemokine ligand 2/monocyte chemoattractant protein-1 expression. We previously found that IL17A promotes aortic infiltration of CD45ϩ leukocytes and CD3ϩ T lymphocytes in response to angiotensin II-induced hypertension. 9 We found that in addition to promoting inflammation, IL17A is necessary for increased vascular superoxide (O 2 ⅐Ϫ ) production in response to high-fat diet-induced atherosclerosis. This is similar to our previous finding that IL17A promotes vascular O 2 ⅐Ϫ production in response to angiotensin II-induced hypertension. 9 The mechanisms by which IL17A induces vascular O 2 ⅐Ϫ production remain unclear. In preliminary studies, we were unable to demonstrate a direct effect of IL17A on O 2 ⅐Ϫ production in either human endothelial or vascular smooth muscle cells in culture; however, a recent report suggests that IL17A can activate the NADPH oxidase in murine vascular smooth muscle cells. 26 It is also possible that IL17A increases superoxide production via recruiting inflammatory cells, which in turn can produce reactive oxygen species.
It is interesting that IL17A modulates a number of factors thought to be associated with plaque progression, such as IFN-␥ production, vascular inflammation, and superoxide production, and yet we did not find any effect on aortic plaque burden or carotid stenosis. Our finding that atherosclerotic plaque burden was similar despite reduced O 2 ⅐Ϫ production is in keeping with prior studies showing that mice overexpressing superoxide dismutase are not protected against atherosclerosis. 27, 28 Moreover, plaque size does not necessarily correlate with clinical outcomes in human coronary atherosclerosis. Plaque stability is more predictive of acute plaque rupture and coronary events. Our findings suggest that IL17A deficiency, through reduced leukocyte infiltration and decreased superoxide production, could stabilize plaques. Thus, IL17A might not be an important determinant of plaque size but rather a modulator of plaque composition and stability. This is in agreement with clinical data showing that Th17 cells and IL17 levels are elevated in patients with unstable angina and acute myocardial infarction compared with patients with stable angina and controls. 8 In our carotid ligation model, we observed that IL17A deficiency had no effect on percentage of stenosis in the ligated vessel, but it markedly decreased outward remodeling. Outward remodeling is a compensatory response to lesion development that preserves lumen diameter in the setting of increasing atherosclerosis burden. In this regard, IL17A Ϫ/Ϫ mice are similar to mice lacking matrix metalloproteinase-9, in which outward remodeling in response to total carotid occlusion is significantly impaired. 29 Because reactive oxygen species are known to increase matrix metalloproteinase-9 expression and activation, 30, 31 it is interesting to speculate that the absence of outward remodeling in the IL17/ApoE Ϫ/Ϫ might reflect the lower levels of O 2 ⅐Ϫ observed in these animals compared with ApoE Ϫ/Ϫ mice.
We also show that IL17/ApoE Ϫ/Ϫ mice are resistant to high-fat diet-induced weight gain. A link between IL17A and obesity was first suggested by a small clinical study showing that plasma levels of IL17A were elevated in 26 obese women compared with 20 lean women. 32 Similar to our findings, Winer et al 33 showed that diet-induced obesity increases IL17 from splenic lymphocytes. Moreover, IL17A stimulates proinflammatory responses in adipocytes. 34 Recently, Pini and Fantuzzi 35 found that neutrophil-derived IL17A is increased in obese mice during acute inflammation and contributes to inflammatory responses. These findings are in keeping with a role of inflammation in the metabolic syndrome and suggest that IL17 might contribute to this disorder.
In summary, using a genetic approach that avoids potential confounding off-target and nonspecific effects, we found that IL17A is involved in systemic and vascular inflammation and weight gain in response to a high-fat diet. Contrary to several prior reports, however, we showed that IL17A is unlikely to contribute significantly to plaque progression. Nevertheless, through its effects on reactive oxygen species and leukocyte infiltration, IL17A is an important potential mediator of plaque stability, and its effects on plaque stability and outward remodeling warrant further investigation.
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